Search

Author/Creator Bouma, Jeanette M.

1. Cost-effectiveness of continuous versus intermittent chemotherapy for patients with HER2-negative advanced breast cancer. (4th May 2022)

Authors:
Claessens, Anouk K. M.; Busschbach, Jan J. V.; Ramaekers, Bram L. T.; Erdkamp, Frans L. G.; Bouma, Jeanette M.; van Leeuwen-Stok, A. Elise; Tjan-Heijnen, Vivianne C. G.; Bos, Monique E. M. M.
Journal:
Acta oncologica
Issue:
Volume 61:Number 5(2022)
Page Start:
619
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancer. (2nd June 2020)

Authors:
Claessens, Anouk K. M.; Erdkamp, Frans L. G.; Lopez-Yurda, Marta; Bouma, Jeanette M.; Rademaker-Lakhai, Jeany M.; Honkoop, Aafke H.; de Graaf, Hiltje; Tjan-Heijnen, Vivianne C. G.; Bos, Monique E. M. M.
Journal:
Acta oncologica
Issue:
Volume 59:Number 6(2020)
Page Start:
713
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search